Market Place
Sourcing Support
Pluristyx Receives U.S. Patent for iACT Stealth™ Technology
11 Feb 2025 //
BUSINESSWIRE
Pluristyx Files Drug Master File for PluriBank™ iPSC Lines with FDA
04 Feb 2025 //
BUSINESSWIRE
Humacyte & Pluristyx to Support BioVascular Pancreas Using iPSCs
28 Jan 2025 //
GLOBENEWSWIRE
Pluristyx Launches GMP-Compliant PSXi013 iPSC Line
07 Jan 2025 //
BUSINESSWIRE
Pluristyx Launches PluriFreeze Cryopreservation Media
04 Apr 2024 //
CONTRACT PHARMA
BioCentriq And Pluristyx Strengthen Partnership For IPSC-NK Cell Therapies
07 Mar 2024 //
PRESS RELEASE
Charles River Collaborates with Pluristyx
20 Feb 2024 //
BUSINESSWIRE
Pluristyx and panCELLa Expand Intellectual Property Portfolio
12 Jan 2023 //
BUSINESSWIRE
Pluristyx, panCELLa, & Implant Therapeutics Announce Definitive Merger Agreement
06 Oct 2022 //
BUSINESSWIRE
Pluristyx and Accelerated Biosciences Enter Clinical Manufacturing Partnership
28 Apr 2022 //
CONTRACTPHARMA
Pluristyx to Support of Kiadis’ K-NK Cell COVID-19 Therapy Funded by $9.5 M
12 Nov 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.